Chris Orvig

Personal Home Page

http://www.chem.ubc.ca/personnel/faculty/orvig/index.shtml

Articles in Scholarly Journals [Incomplete List]

  1. Combating Alzheimer's Disease With Multifunctional Molecules Designed for Metal Passivation
    Angewandte Chemie International Edition, vol. 46, no. 10, pp. 1716–1718, 2007
  2. Vanadium in diabetes: 100 years from Phase 0 to Phase I
    Journal of Inorganic Biochemistry, vol. 100, no. 12, pp. 1925–1935, 2006
  3. Bioconjugate Chemistry, vol. 17, no. 5, pp. 1321–1329, 2006
  4. Inorganic Chemistry, vol. 45, no. 20, pp. 8414–8422, 2006
  5. Inorganic Chemistry, vol. 45, no. 17, pp. 6979–6987, 2006
  6. Metal complexes of maltol and close analogues in medicinal inorganic chemistry
    Chemical Society Reviews, vol. 35, no. 6, p. 545, 2006
  7. Lanthanide(iii) and group 13 metal ion complexes of tripodal amino phosphinate ligands
    Dalton Transactions, no. 1, p. 31, 2006
  8. Design of targeting ligands in medicinal inorganic chemistry
    Chemical Society Reviews, vol. 35, no. 6, p. 534, 2006
  9. Editorial: Lanthanide compounds for therapeutic and diagnostic applications
    Chemical Society Reviews, vol. 35, no. 6, p. 499, 2006
  10. Metal complexes in medicinal chemistry: new vistas and challenges in drug design
    Dalton Transactions, no. 6, p. 761, 2006
  11. Coordination chemistry of P, O-bidentate phosphinophenolates with Ga3+ and In3+
    Dalton Transactions, no. 13, p. 2268, 2005
  12. A glucosamine?dipicolylamine conjugate of 99mTc(i) and 186Re(i) for use in imaging and therapy
    Dalton Transactions, no. 4, p. 654, 2005
  13. Inorganic Chemistry, vol. 44, no. 8, pp. 2698–2705, 2005
  14. Inorganic Chemistry, vol. 44, no. 8, pp. 2678–2688, 2005
  15. Inorganic Chemistry, vol. 44, no. 8, pp. 2666–2677, 2005
  16. Journal of the American Chemical Society, vol. 127, no. 14, pp. 5104–5115, 2005
  17. Inorganic Chemistry, vol. 44, no. 8, pp. 2689–2697, 2005
  18. Novel Carbohydrate-Appended Metal Complexes for Potential Use in Molecular Imaging
    Chemistry - A European Journal, vol. 11, no. 1, pp. 195–203, 2005
  19. Synthesis and characterization of dual function vanadyl, gallium and indium curcumin complexes for medicinal applications
    Journal of Inorganic Biochemistry, vol. 99, no. 11, pp. 2217–2225, 2005
  20. Synthesis and insulin-mimetic activities of metal complexes with 3-hydroxypyridine-2-carboxylic acid
    Journal of Inorganic Biochemistry, vol. 99, no. 6, pp. 1275–1282, 2005
  21. Bioconjugate Chemistry, vol. 16, no. 6, pp. 1597–1609, 2005
  22. Complementary inhibition of synoviocyte, smooth muscle cell or mouse lymphoma cell proliferation by a vanadyl curcumin complex compared to curcumin alone
    Journal of Inorganic Biochemistry, vol. 98, no. 12, pp. 2063–2070, 2004
  23. Comparison of anti-hyperglycemic effect amongst vanadium, molybdenum and other metal maltol complexes
    Journal of Inorganic Biochemistry, vol. 98, no. 5, pp. 683–690, 2004
  24. Synthesis and insulinomimetic activities of novel mono- and tetranuclear oxovanadium(IV) complexes with 3-hydroxypyridine-2-carboxylic acid
    Journal of Inorganic Biochemistry, vol. 98, no. 1, pp. 105–112, 2004
  25. Bioconjugate Chemistry, vol. 15, no. 4, pp. 923–926, 2004
  26. Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential
    Journal of Biological Inorganic Chemistry, vol. 8, no. 1-2, pp. 66–74, 2003
  27. Inorganic Chemistry, vol. 42, no. 5, pp. 1576–1583, 2003
  28. Bioconjugate Chemistry, vol. 14, no. 1, pp. 212–221, 2003
  29. Chronic glucose-lowering effects of rosiglitazone and bis(ethylmaltolato)oxovanadium(IV) in ZDF rats
    Canadian Journal of Physiology and Pharmacology, vol. 81, no. 11, pp. 1049–1055, 2003
  30. Boon and Bane of Metal Ions in Medicine
    Science, vol. 300, no. 5621, pp. 936–939, 2003
  31. Influence of Chelation and Oxidation State on Vanadium Bioavailability, and Their Effects on Tissue Concentrations of Zinc, Copper, and Iron
    Biological Trace Element Research, vol. 86, no. 1, pp. 31–44, 2002
  32. Molecular and Cellular Biochemistry, vol. 231, no. 1/2, pp. 23–35, 2002
  33. Mononuclear to Tetranuclear Structural Transformation in Vanadyl Complexes of 3-Hydroxypyridine-2-carboxylic Acid (H2hpic)
    Chemistry Letters, no. 9, pp. 916–917, 2002
  34. Journal of the American Chemical Society, vol. 124, no. 12, pp. 2969–2978, 2002
  35. Inorganic Chemistry, vol. 41, no. 4, pp. 685–692, 2002
  36. Inorganic Chemistry, vol. 41, no. 6, pp. 1357–1364, 2002
  37. Synthesis and solution studies of the complexes of pyrone analogue ligands with vanadium(IV) and vanadium(V)
    Inorganica Chimica Acta, vol. 339, pp. 393–399, 2002
  38. Unprecedented sugar-dependent in vivo antitumor activity of carbohydrate-pendant cis-diamminedichloroplatinum(II) complexes
    Bioorganic & Medicinal Chemistry Letters, vol. 11, no. 23, pp. 3045–3047, 2001
  39. Inorganic Chemistry, vol. 40, no. 15, pp. 3734–3738, 2001
  40. Inorganic Chemistry, vol. 40, no. 18, pp. 4623–4626, 2001
  41. Inorganic Chemistry, vol. 40, no. 7, pp. 1527–1535, 2001
  42. Inorganic Chemistry, vol. 40, no. 18, pp. 4686–4690, 2001
  43. Inorganic Chemistry, vol. 40, no. 9, pp. 2005–2010, 2001
  44. Coordination chemistry of vanadium in metallopharmaceutical candidate compounds
    Coordination Chemistry Reviews, vol. 219-221, pp. 1033–1053, 2001
  45. Proton- and lanthanide-coordinating properties of the tetraaza macrocycle (EDDA-KA)2 in aqueous solution
    Canadian Journal of Chemistry, vol. 79, no. 5-6, pp. 1058–1067, 2001
  46. Complexes of phosphineââ?¬â??phenolate ligands with the [Reîâ?¬ÂO]3+ and [Re(HNNC5H4N)(NNC5H4N)]2+ cores
    Journal of the Chemical Society, Dalton Transactions, no. 20, pp. 3015–3024, 2001
  47. Acid–base and metal ion-binding properties of diaminopropyl D-glucopyranoside and diaminopropyl D-mannopyranoside compounds in aqueous solution
    Journal of the Chemical Society, Dalton Transactions, no. 8, pp. 1325–1333, 2000
  48. Design of vanadium compounds as insulin enhancing agents
    Journal of the Chemical Society, Dalton Transactions, no. 17, pp. 2885–2892, 2000
  49. Inorganic Chemistry, vol. 39, no. 3, pp. 508–516, 2000
  50. Inorganic Chemistry, vol. 39, no. 3, pp. 496–507, 2000
  51. Inorganic Chemistry, vol. 39, no. 26, pp. 5958–5963, 2000
  52. Vanadyl–biguanide complexes as potential synergistic insulin mimics
    Journal of Inorganic Biochemistry, vol. 76, no. 3-4, pp. 251–257, 1999
  53. Inorganic Chemistry, vol. 38, no. 10, pp. 2288–2293, 1999
  54. Journal of the American Chemical Society, vol. 121, no. 47, pp. 11004–11005, 1999
  55. Chemical Reviews, vol. 99, no. 9, pp. 2561–2572, 1999
  56. Cationic iron(III) complex with a hexadentate N2,N'2',O2-aminopyridylphenolate ligand
    Canadian Journal of Chemistry, vol. 77, no. 12, pp. 2033–2038, 1999
  57. Tripodal trisamides based on nicotinic and picolinic acid derivatives
    Canadian Journal of Chemistry, vol. 76, no. 4, pp. 414–425, 1998
  58. Complexation of Ni2+ and Cu2+ by tripodal amine phenol ligands in aqueous solution?†
    Journal of the Chemical Society, Dalton Transactions, no. 18, pp. 3049–3056, 1998
  59. Inorganic Chemistry, vol. 37, no. 7, pp. 1637–1647, 1998
  60. Inorganic Chemistry, vol. 37, no. 16, pp. 4022–4029, 1998
  61. Inorganic Chemistry, vol. 37, no. 12, pp. 3119–3121, 1998
  62. Complexation of gallium(III) by 2-hydroxynicotinic acid and 3-hydroxypicolinic acid in aqueous solution
    Inorganica Chimica Acta, vol. 273, no. 1-2, pp. 47–53, 1998
  63. Active Oxygen Species Formation in Synaptosomes Exposed to an Aluminum Chelator
    Neurotoxicology and Teratology, vol. 20, no. 3, pp. 317–320, 1998
  64. Glucose-lowering properties of vanadium compounds: Comparison of coordination complexes with maltol or kojic acid as ligands
    Journal of Inorganic Biochemistry, vol. 68, no. 2, pp. 109–116, 1997
  65. Selectivity among, and aggregation of, lanthanide ions
    Journal of Alloys and Compounds, vol. 249, no. 1-2, pp. 49–51, 1997
  66. Inorganic Chemistry, vol. 36, no. 2, pp. 236–248, 1997
  67. Inorganic Chemistry, vol. 36, no. 7, pp. 1306–1315, 1997
  68. Inorganic Chemistry, vol. 36, no. 7, pp. 1316–1321, 1997
  69. Inorganic Chemistry, vol. 35, no. 6, pp. 1667–1673, 1996
  70. Inorganic Chemistry, vol. 35, no. 26, pp. 7798–7803, 1996
  71. Inorganic Chemistry, vol. 35, no. 22, pp. 6507–6512, 1996
  72. Inorganic Chemistry, vol. 35, no. 3, pp. 715–724, 1996
  73. SPECIATION OF ALUMINUM IN BIOLOGICAL SYSTEMS
    Journal of Toxicology and Environmental Health Part A, vol. 48, no. 6, pp. 543–568, 1996
  74. (Acetonitrile)[N,N-bis(3-aminopropyl)-1,3-propanediamine-N,N',N'',N''']copper(II) Diperchlorate
    Acta Crystallographica Section C Crystal Structure Communications, vol. 52, no. 8, pp. 1957–1959, 1996
  75. Effects of low and high dose administration of bis(maltolato)oxovanadium(IV) on fa/fa Zucker rats
    Canadian Journal of Physiology and Pharmacology, vol. 74, no. 9, pp. 1001–1015, 1996
  76. trans-Tetrachlorobis(triphenylphosphine-P)rhenium(IV)–mer-trans-Trichlorooxobis(triphenylphosphine-P)rhenium(V) (0.86/0.14)
    Acta Crystallographica Section C Crystal Structure Communications, vol. 52, no. 6, pp. 1377–1380, 1996
  77. Inorganic Chemistry, vol. 35, no. 2, pp. 368–372, 1996
  78. Journal of the American Chemical Society, vol. 117, no. 51, pp. 12759–12770, 1995
  79. Inorganic Chemistry, vol. 34, no. 11, pp. 3057–3064, 1995
  80. Journal of the American Chemical Society, vol. 117, no. 45, pp. 11230–11238, 1995
  81. Inorganic Chemistry, vol. 34, no. 9, pp. 2287–2299, 1995
  82. Evidence for energy-dependent transport of aluminum out of brain extracellular fluid
    Toxicology, vol. 98, no. 1-3, pp. 31–39, 1995
  83. Inorganic Chemistry, vol. 34, no. 8, pp. 2164–2178, 1995
  84. Inorganic Chemistry, vol. 34, no. 1, pp. 93–101, 1995
  85. Inorganic Chemistry, vol. 34, no. 19, pp. 4921–4925, 1995
  86. Increased potency of vanadium using organic ligands
    Molecular and Cellular Biochemistry, vol. 153, no. 1-2, pp. 175–180, 1995
  87. Inorganic Chemistry, vol. 33, no. 24, pp. 5607–5609, 1994
  88. Pharmacokinetics of aluminum 3-hydroxypyridin-4-one complexes: implications for aluminum redistribution subsequent to chelation therapy
    Toxicology, vol. 92, no. 1-3, pp. 193–202, 1994
  89. Inorganic Chemistry, vol. 32, no. 21, pp. 4491–4497, 1993
  90. Inorganic Chemistry, vol. 32, no. 22, pp. 4909–4913, 1993
  91. Inorganic Chemistry, vol. 32, no. 20, pp. 4268–4276, 1993
  92. Inorganic Chemistry, vol. 32, no. 9, pp. 1756–1765, 1993
  93. Inorganic Chemistry, vol. 32, no. 12, pp. 2773–2778, 1993
  94. Potential 99mTc radiopharmaceuticals for renal imaging: Tris(N-substituted-3-hydroxy-2-methyl-4-pyridinonato)technetium(IV) cations
    Nuclear Medicine and Biology, vol. 20, no. 7, pp. 857–863, 1993
  95. Inorganic Chemistry, vol. 31, no. 26, pp. 5400–5407, 1992
  96. Inorganic Chemistry, vol. 31, no. 26, pp. 5408–5416, 1992
  97. General method for the synthesis of trishydroxamic acids
    Tetrahedron Letters, vol. 33, no. 14, pp. 1827–1830, 1992
  98. Journal of Medicinal Chemistry, vol. 35, no. 8, pp. 1489–1491, 1992
  99. Inorganic Chemistry, vol. 30, no. 3, pp. 509–515, 1991
  100. Inorganic Chemistry, vol. 30, no. 26, pp. 4915–4919, 1991
  101. Journal of the American Chemical Society, vol. 113, no. 7, pp. 2528–2532, 1991
  102. Inorganic Chemistry, vol. 29, no. 4, pp. 667–672, 1990
  103. Inorganic Chemistry, vol. 28, no. 16, pp. 3153–3157, 1989
  104. Inorganic Chemistry, vol. 28, no. 4, pp. 715–719, 1989
  105. Inorganic Chemistry, vol. 28, no. 11, pp. 2079–2081, 1989
  106. Inorganic Chemistry, vol. 27, no. 22, pp. 3929–3934, 1988
  107. Inorganic Chemistry, vol. 27, no. 6, pp. 1045–1051, 1988
  108. Inorganic Chemistry, vol. 27, no. 22, pp. 3935–3939, 1988
  109. Journal of the American Chemical Society, vol. 109, no. 13, pp. 4121–4123, 1987
  110. Inorganic Chemistry, vol. 26, no. 13, pp. 2171–2176, 1987
  111. Journal of the American Chemical Society, vol. 108, no. 16, pp. 5033–5035, 1986